Dendritic cells and T cells in immunotherapy |
| |
Authors: | O'Neill David W |
| |
Affiliation: | NYU School of Medicine, NYU Cancer Institute, Vaccine and Cell Therapy Core Laboratory, New York, NY 10011, USA. oneilld8@gmail.com |
| |
Abstract: | Autologous cellular immunotherapies have been used experimentally in humans to treat many types of cancer. These therapies are divided into two principal types: active cellular immunotherapies that rely on autologous dendritic cells or other antigen presenting cells; and adoptive T-cell therapies, in which large numbers of antigen-specific T lymphocytes are propagated ex vivo and then infused back into the patient. With the FDA approval of the antigen presenting cell vaccine sipuleucel-T for prostate cancer, active immunization has become an accepted approach for the treatment of established cancer. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|